SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000912282-24-000243
Filing Date
2024-03-12
Accepted
2024-03-12 16:17:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 39533
2 image0.jpg GRAPHIC 2979
  Complete submission text file 0000912282-24-000243.txt   45248
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
Scinai Immunotherapeutics Ltd. (Subject) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89384 | Film No.: 24742292
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1200 BRICKELL AVENUE, #1470 MIAMI FL 33131
Business Address
STONE DANIEL E. (Filed by) CIK: 0001948744 (see all company filings)

Type: SC 13D